Global Pediatric Vaccine Market (2020-2025) by Vaccine Type, Technology, Application, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis

The Global Pediatric Vaccines Market is estimated to be USD 45 Bn in 2020 and is expected to reach USD 74.5 Bn by 2025, growing at a CAGR of 10.6%.



Certain factors, such as the rising number of chronic diseases across the globe along with the initiatives taken by the Governments towards promoting vaccination have been major drivers of growth for the pediatric market. Additionally, increasing awareness about the importance of pediatric vaccination in the prevention of diseases is expected to fuel market growth.

However, the costs attached to immunization and the low level of accessibility in low-income countries restrain the growth of this market. The increasing availability of biosimilars at low rates is also creating hindrances for the market.

Market Dynamics

Drivers

• Rising Burden of Chronic Diseases
• Favorable Government Support in Promoting Vaccination
• Growing Importance and Awareness of Immunization

Restraints

• Cost of Immunization
• Low Medical Coverage and Healthcare Services in Low-income and Middle-income Countries

Opportunities

• Rising Number of Collaborations, Expansions, and Mergers
• Technological Advancements in Vaccines

Challenges

• Stringent Regulatory Compliance in the Development of Vaccines
• Refusal of Immunization due to Low Awareness and Vaccines Shortages

Segments Covered

By Vaccine Type, the Monovalent Vaccine is estimated to account for the fastest-growing segment during the forecast period. It has been noted that many of the newly approved pediatric vaccines, as well as existing pediatric vaccines today, are monovalent vaccines, thus adding to the market growth.

By Technology, the Conjugate/Subunit Vaccines segment is estimated to be the fastest-growing segment during the forecast period. It is due to the high immune response provided to the body by the vaccine to fight against specific types of microorganisms. Thus, the rising number of regulatory approvals for conjugate vaccines have been major promoters of growth.

By Application, the Infectious Diseases Segment holds the largest share due to rising global awareness about immunization against infectious diseases that cause death. An increase in the incidence of chickenpox, typhoid, cholera, measles, and hepatitis, etc. in infants results in high demand for immunization, which positively impacts the market.

By Geography, North America is anticipated to lead the market. The factors attributed to the growth of the market are the growing incidences of infectious diseases, availability of reimbursement schemes, new product approvals, and high spending and initiatives taken by the Government in the healthcare industry. The European market is also expected to grow due to the ease of operability, efficient resource planning, a large number of pharmaceutical manufacturers, and rising government funding.

The Global Pediatric Vaccine market is further segmented on the basis of Vaccine Type, Technology, Application, and Geography.

Global Pediatric Vaccines Market, By Vaccine Type

• Introduction
• Monovalent
• Multivalent

Global Pediatric Vaccines Market, By Technology

• Introduction
• Live Attenuated
• Inactivated
• Subunits
• Toxoid
• Conjugate
• Other Technologies

Global Pediatric Vaccines Market, By Application

• Introduction
• Infectious Diseases
• Cancer
• Allergies
• Other Applications

Global Pediatric Vaccines Market, By Geography

• Introduction
• North America
• South America
• Europe
• Asia Pacific
• Rest of the World

Company Profiles

Some of the companies covered in this report are Sanofi S.A., GlaxoSmithKline plc, Merck & Co., Inc., Pfizer Inc., Grifols, Serum Institute of India Pvt. Ltd., AstraZeneca, Cadila Healthcare Ltd, Indian Immunologicals Limited, and CSL Limited.

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Why buy this report?

• The report offers a comprehensive evaluation of the Global Pediatric Vaccines Market. The report includes an in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
• The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
• The report includes an in-depth market analysis using Porter’s 5 force model and the Ansoff Matrix. The impact of Covid-19 on the market is also featured in the report.

The report also contains a competitive analysis using a Competitive Quadrant, the analyst's proprietary competitive positioning tool.

Report Highlights:

• A complete analysis of the market including parent industry
• Important market dynamics and trends
• Market segmentation
• Historical, current, and projected size of the market based on value and volume
• Market shares and strategies of key players
• Recommendations to companies for strengthening their foothold in the market